COVID-19 Seems To Immediately Reoccur In Some After Treatment With Paxlovid – CDC Advisory Explained

Share

The CDC has issued a formal advisory on the drug Paxlovid used to treat COVID-19 after a number of cases have been identified of COVID-19 immediately returning days after recovering from initial illness treated with Paxlovid. We discuss what exactly the data is behind all of this and what it may mean to you.


Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2 https://www.nejm.org/doi/10.1056/NEJM…

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 https://www.nejm.org/doi/full/10.1056…

https://emergency.cdc.gov/han/2022/ha…

Additional related videos!

Pfizer’s New COVID-19 Treatment Paxlovid: Decreased Mortality By 89%? Everything You Should Know https://www.youtube.com/watch?v=HgBrp…

Omicron Subvariant BA.2.12.1 Mutations, Spread, Contagiousness, Symptoms, Severity, Immune Escape https://www.youtube.com/watch?v=SvgzA…

DISCLAIMER:

THIS VIDEO DOES NOT PROVIDE MEDICAL ADVICE. The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read, watched, or listened to on this video, or any other videos, reports, texts tweets or other sources.